This website is intended for healthcare professionals only.
Hospital Pharmacy Europe
Newsletter
Login
News
In depth
Views
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Oncology
Paediatrics
Pathology and diagnostics
Radiology and imaging
Respiratory
Rheumatology
Insight and Analysis
Q&As
European healthcare data
Webinars
Country profiles
Events
Sponsored
Newsletter
Hospital Pharmacy Europe
Covid-19
Dupilumab reduces COVID-19 symptom burden in patients with atopic eczema
Read more
RoActemra (tocilizumab) approved by EMA for use in severe COVID-19
Read more
mRNA-1273 vaccine associated with lower risk of COVID-19 outcomes than BNT162b
Read more
Comirnaty COVID-19 booster shows greater than 90% effectiveness in over 50s
Read more
Omicron variant nearly three-times more likely to cause re-infection
Read more
Xevudy (sotrovimab) approved by MHRA for mild to moderate COVID-19
Read more
RAAS inhibition reduces COVID-19 mortality within intensive care
Read more
Comirnaty COVID-19 vaccine approved by EMA for children aged 5 – 11
Read more
Ciclesonide no better than placebo for COVID-19 symptom resolution
Read more
Eye protection appears to reduce COVID-19 infection in healthcare workers
Read more
Haematological cancer patients at increased risk of severe breakthrough COVID-19 infections
Read more
Cancer diagnoses in young people fell but ICU admissions increased during first wave of pandemic
Read more
Breast milk found to contain neutralising COVID-19 antibodies
Read more
Regdanvimab recommended as a treatment for COVID-19 by the CHMP
Read more
Paxlovid reduces hospitalisation and death in COVID-19
Read more
MHRA approves Lagevrio (molnupiravir)
Read more
Fluvoxamine in high-risk COVID-19 patients reduces time spent at hospital
Read more
Page 9 of 27
« First
«
...
7
8
9
10
11
...
20
...
»
Last »
Popular articles
New protocol for IBD referral triage reduces diagnostic delays, say researchers
24 April, 2024
Ivacaftor use in cystic fibrosis ‘safe and effective’ from one month old, study finds
25 April, 2024
Semaglutide shows promise in patients with type 2 diabetes and obesity-related heart failure
22 April, 2024
x
Search for: